nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CYP3A4—type 2 diabetes mellitus	0.255	1	CbGaD
Ipratropium bromide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0395	0.101	CbGbCtD
Ipratropium bromide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.039	0.0999	CbGbCtD
Ipratropium bromide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0364	0.0934	CbGbCtD
Ipratropium bromide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0347	0.089	CbGbCtD
Ipratropium bromide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0318	0.0814	CbGbCtD
Ipratropium bromide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0299	0.0767	CbGbCtD
Ipratropium bromide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0287	0.0735	CbGbCtD
Ipratropium bromide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0278	0.0711	CbGbCtD
Ipratropium bromide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0251	0.0643	CbGbCtD
Ipratropium bromide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.019	0.0488	CbGbCtD
Ipratropium bromide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0182	0.0468	CbGbCtD
Ipratropium bromide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0182	0.0468	CbGbCtD
Ipratropium bromide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0172	0.0442	CbGbCtD
Ipratropium bromide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0129	0.0329	CbGbCtD
Ipratropium bromide—CYP3A4—Losartan—type 2 diabetes mellitus	0.0118	0.0301	CbGbCtD
Ipratropium bromide—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000192	0.000754	CcSEcCtD
Ipratropium bromide—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000192	0.000754	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000192	0.000753	CcSEcCtD
Ipratropium bromide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000192	0.000753	CcSEcCtD
Ipratropium bromide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000191	0.000752	CcSEcCtD
Ipratropium bromide—Hypertension—Metformin—type 2 diabetes mellitus	0.00019	0.000748	CcSEcCtD
Ipratropium bromide—Urticaria—Glyburide—type 2 diabetes mellitus	0.00019	0.000748	CcSEcCtD
Ipratropium bromide—Nervousness—Losartan—type 2 diabetes mellitus	0.00019	0.000748	CcSEcCtD
Ipratropium bromide—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00019	0.000747	CcSEcCtD
Ipratropium bromide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00019	0.000746	CcSEcCtD
Ipratropium bromide—Back pain—Losartan—type 2 diabetes mellitus	0.00019	0.000745	CcSEcCtD
Ipratropium bromide—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000189	0.000744	CcSEcCtD
Ipratropium bromide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000189	0.000744	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000189	0.000742	CcSEcCtD
Ipratropium bromide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000188	0.000739	CcSEcCtD
Ipratropium bromide—Myalgia—Metformin—type 2 diabetes mellitus	0.000188	0.000738	CcSEcCtD
Ipratropium bromide—Chest pain—Metformin—type 2 diabetes mellitus	0.000188	0.000738	CcSEcCtD
Ipratropium bromide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000187	0.000734	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000187	0.000733	CcSEcCtD
Ipratropium bromide—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000186	0.000731	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000186	0.00073	CcSEcCtD
Ipratropium bromide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000186	0.000729	CcSEcCtD
Ipratropium bromide—Nausea—Glipizide—type 2 diabetes mellitus	0.000185	0.000727	CcSEcCtD
Ipratropium bromide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000185	0.000726	CcSEcCtD
Ipratropium bromide—Hypotension—Valsartan—type 2 diabetes mellitus	0.000185	0.000726	CcSEcCtD
Ipratropium bromide—Vision blurred—Losartan—type 2 diabetes mellitus	0.000185	0.000726	CcSEcCtD
Ipratropium bromide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000184	0.000724	CcSEcCtD
Ipratropium bromide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000184	0.000723	CcSEcCtD
Ipratropium bromide—Pain—Gliclazide—type 2 diabetes mellitus	0.000184	0.000723	CcSEcCtD
Ipratropium bromide—Tremor—Losartan—type 2 diabetes mellitus	0.000184	0.000721	CcSEcCtD
Ipratropium bromide—Rash—Glimepiride—type 2 diabetes mellitus	0.000183	0.00072	CcSEcCtD
Ipratropium bromide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000183	0.000719	CcSEcCtD
Ipratropium bromide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000183	0.000718	CcSEcCtD
Ipratropium bromide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000182	0.000717	CcSEcCtD
Ipratropium bromide—Headache—Glimepiride—type 2 diabetes mellitus	0.000182	0.000715	CcSEcCtD
Ipratropium bromide—Cough—Irbesartan—type 2 diabetes mellitus	0.000182	0.000714	CcSEcCtD
Ipratropium bromide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000181	0.000713	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00018	0.000708	CcSEcCtD
Ipratropium bromide—Oedema—Metformin—type 2 diabetes mellitus	0.00018	0.000707	CcSEcCtD
Ipratropium bromide—Tinnitus—Ramipril—type 2 diabetes mellitus	0.00018	0.000707	CcSEcCtD
Ipratropium bromide—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00018	0.000706	CcSEcCtD
Ipratropium bromide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000179	0.000705	CcSEcCtD
Ipratropium bromide—Flushing—Ramipril—type 2 diabetes mellitus	0.000179	0.000704	CcSEcCtD
Ipratropium bromide—Angioedema—Losartan—type 2 diabetes mellitus	0.000179	0.000703	CcSEcCtD
Ipratropium bromide—Infection—Metformin—type 2 diabetes mellitus	0.000179	0.000703	CcSEcCtD
Ipratropium bromide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000179	0.000703	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000178	0.000699	CcSEcCtD
Ipratropium bromide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000178	0.000698	CcSEcCtD
Ipratropium bromide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000177	0.000696	CcSEcCtD
Ipratropium bromide—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000177	0.000696	CcSEcCtD
Ipratropium bromide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000177	0.000694	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000177	0.000694	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000177	0.000694	CcSEcCtD
Ipratropium bromide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000176	0.000693	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000176	0.000692	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000176	0.000691	CcSEcCtD
Ipratropium bromide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000176	0.000691	CcSEcCtD
Ipratropium bromide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000175	0.000689	CcSEcCtD
Ipratropium bromide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000175	0.000687	CcSEcCtD
Ipratropium bromide—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000174	0.000685	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000174	0.000684	CcSEcCtD
Ipratropium bromide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000174	0.000684	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000174	0.000683	CcSEcCtD
Ipratropium bromide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000173	0.000681	CcSEcCtD
Ipratropium bromide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000173	0.000681	CcSEcCtD
Ipratropium bromide—Palpitations—Losartan—type 2 diabetes mellitus	0.000173	0.00068	CcSEcCtD
Ipratropium bromide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000173	0.000678	CcSEcCtD
Ipratropium bromide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000172	0.000676	CcSEcCtD
Ipratropium bromide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000172	0.000676	CcSEcCtD
Ipratropium bromide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000172	0.000676	CcSEcCtD
Ipratropium bromide—Cough—Losartan—type 2 diabetes mellitus	0.000171	0.000672	CcSEcCtD
Ipratropium bromide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000171	0.000672	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000171	0.000671	CcSEcCtD
Ipratropium bromide—Fatigue—Valsartan—type 2 diabetes mellitus	0.00017	0.00067	CcSEcCtD
Ipratropium bromide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00017	0.000668	CcSEcCtD
Ipratropium bromide—Oedema—Irbesartan—type 2 diabetes mellitus	0.00017	0.000668	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00017	0.000668	CcSEcCtD
Ipratropium bromide—Pruritus—Glyburide—type 2 diabetes mellitus	0.00017	0.000666	CcSEcCtD
Ipratropium bromide—Constipation—Valsartan—type 2 diabetes mellitus	0.000169	0.000664	CcSEcCtD
Ipratropium bromide—Infection—Irbesartan—type 2 diabetes mellitus	0.000169	0.000663	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000169	0.000663	CcSEcCtD
Ipratropium bromide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000168	0.000662	CcSEcCtD
Ipratropium bromide—Hypotension—Metformin—type 2 diabetes mellitus	0.000168	0.000661	CcSEcCtD
Ipratropium bromide—Pain—Orlistat—type 2 diabetes mellitus	0.000167	0.000656	CcSEcCtD
Ipratropium bromide—Myalgia—Losartan—type 2 diabetes mellitus	0.000167	0.000655	CcSEcCtD
Ipratropium bromide—Chest pain—Losartan—type 2 diabetes mellitus	0.000167	0.000655	CcSEcCtD
Ipratropium bromide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000167	0.000655	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000167	0.000655	CcSEcCtD
Ipratropium bromide—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000166	0.000652	CcSEcCtD
Ipratropium bromide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000165	0.00065	CcSEcCtD
Ipratropium bromide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000165	0.000649	CcSEcCtD
Ipratropium bromide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000165	0.000649	CcSEcCtD
Ipratropium bromide—Tension—Ramipril—type 2 diabetes mellitus	0.000165	0.000648	CcSEcCtD
Ipratropium bromide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000165	0.000646	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000164	0.000645	CcSEcCtD
Ipratropium bromide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000164	0.000645	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000164	0.000645	CcSEcCtD
Ipratropium bromide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000164	0.000644	CcSEcCtD
Ipratropium bromide—Nervousness—Ramipril—type 2 diabetes mellitus	0.000163	0.000641	CcSEcCtD
Ipratropium bromide—Dry mouth—Losartan—type 2 diabetes mellitus	0.000163	0.000641	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000162	0.000635	CcSEcCtD
Ipratropium bromide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000162	0.000635	CcSEcCtD
Ipratropium bromide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000161	0.000631	CcSEcCtD
Ipratropium bromide—Somnolence—Metformin—type 2 diabetes mellitus	0.00016	0.000629	CcSEcCtD
Ipratropium bromide—Oedema—Losartan—type 2 diabetes mellitus	0.00016	0.000628	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00016	0.000628	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00016	0.000628	CcSEcCtD
Ipratropium bromide—Infection—Losartan—type 2 diabetes mellitus	0.000159	0.000624	CcSEcCtD
Ipratropium bromide—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000159	0.000624	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000159	0.000623	CcSEcCtD
Ipratropium bromide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000158	0.000623	CcSEcCtD
Ipratropium bromide—Tremor—Ramipril—type 2 diabetes mellitus	0.000157	0.000618	CcSEcCtD
Ipratropium bromide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000157	0.000617	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000157	0.000616	CcSEcCtD
Ipratropium bromide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000156	0.000614	CcSEcCtD
Ipratropium bromide—Tachycardia—Losartan—type 2 diabetes mellitus	0.000156	0.000613	CcSEcCtD
Ipratropium bromide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000156	0.000612	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000155	0.000611	CcSEcCtD
Ipratropium bromide—Fatigue—Metformin—type 2 diabetes mellitus	0.000155	0.00061	CcSEcCtD
Ipratropium bromide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000155	0.00061	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000155	0.000608	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000155	0.000607	CcSEcCtD
Ipratropium bromide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000154	0.000607	CcSEcCtD
Ipratropium bromide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000154	0.000607	CcSEcCtD
Ipratropium bromide—Constipation—Metformin—type 2 diabetes mellitus	0.000154	0.000605	CcSEcCtD
Ipratropium bromide—Angioedema—Ramipril—type 2 diabetes mellitus	0.000154	0.000603	CcSEcCtD
Ipratropium bromide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000153	0.0006	CcSEcCtD
Ipratropium bromide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000152	0.000599	CcSEcCtD
Ipratropium bromide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000152	0.000598	CcSEcCtD
Ipratropium bromide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000151	0.000595	CcSEcCtD
Ipratropium bromide—Rash—Glyburide—type 2 diabetes mellitus	0.000151	0.000594	CcSEcCtD
Ipratropium bromide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000151	0.000594	CcSEcCtD
Ipratropium bromide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000151	0.000593	CcSEcCtD
Ipratropium bromide—Headache—Glyburide—type 2 diabetes mellitus	0.00015	0.00059	CcSEcCtD
Ipratropium bromide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00015	0.000588	CcSEcCtD
Ipratropium bromide—Hypotension—Losartan—type 2 diabetes mellitus	0.000149	0.000587	CcSEcCtD
Ipratropium bromide—Palpitations—Ramipril—type 2 diabetes mellitus	0.000148	0.000583	CcSEcCtD
Ipratropium bromide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000147	0.000579	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000147	0.000579	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000147	0.000576	CcSEcCtD
Ipratropium bromide—Cough—Ramipril—type 2 diabetes mellitus	0.000147	0.000576	CcSEcCtD
Ipratropium bromide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000146	0.000576	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000146	0.000572	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000146	0.000572	CcSEcCtD
Ipratropium bromide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000145	0.000571	CcSEcCtD
Ipratropium bromide—Pain—Irbesartan—type 2 diabetes mellitus	0.000145	0.000571	CcSEcCtD
Ipratropium bromide—Insomnia—Losartan—type 2 diabetes mellitus	0.000145	0.000568	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000144	0.000566	CcSEcCtD
Ipratropium bromide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000144	0.000564	CcSEcCtD
Ipratropium bromide—Urticaria—Metformin—type 2 diabetes mellitus	0.000143	0.000562	CcSEcCtD
Ipratropium bromide—Chest pain—Ramipril—type 2 diabetes mellitus	0.000143	0.000562	CcSEcCtD
Ipratropium bromide—Myalgia—Ramipril—type 2 diabetes mellitus	0.000143	0.000562	CcSEcCtD
Ipratropium bromide—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000143	0.00056	CcSEcCtD
Ipratropium bromide—Nausea—Glyburide—type 2 diabetes mellitus	0.000142	0.000559	CcSEcCtD
Ipratropium bromide—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000142	0.000559	CcSEcCtD
Ipratropium bromide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000142	0.000559	CcSEcCtD
Ipratropium bromide—Somnolence—Losartan—type 2 diabetes mellitus	0.000142	0.000559	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000142	0.000558	CcSEcCtD
Ipratropium bromide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000142	0.000557	CcSEcCtD
Ipratropium bromide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000141	0.000553	CcSEcCtD
Ipratropium bromide—Asthenia—Orlistat—type 2 diabetes mellitus	0.00014	0.000551	CcSEcCtD
Ipratropium bromide—Pruritus—Valsartan—type 2 diabetes mellitus	0.00014	0.00055	CcSEcCtD
Ipratropium bromide—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00014	0.00055	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000139	0.000546	CcSEcCtD
Ipratropium bromide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000138	0.000543	CcSEcCtD
Ipratropium bromide—Fatigue—Losartan—type 2 diabetes mellitus	0.000138	0.000542	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000137	0.000539	CcSEcCtD
Ipratropium bromide—Oedema—Ramipril—type 2 diabetes mellitus	0.000137	0.000539	CcSEcCtD
Ipratropium bromide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000137	0.000538	CcSEcCtD
Ipratropium bromide—Pain—Losartan—type 2 diabetes mellitus	0.000137	0.000537	CcSEcCtD
Ipratropium bromide—Constipation—Losartan—type 2 diabetes mellitus	0.000137	0.000537	CcSEcCtD
Ipratropium bromide—Rash—Gliclazide—type 2 diabetes mellitus	0.000136	0.000533	CcSEcCtD
Ipratropium bromide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000136	0.000533	CcSEcCtD
Ipratropium bromide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000135	0.000532	CcSEcCtD
Ipratropium bromide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000135	0.00053	CcSEcCtD
Ipratropium bromide—Headache—Gliclazide—type 2 diabetes mellitus	0.000135	0.00053	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000134	0.000528	CcSEcCtD
Ipratropium bromide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000134	0.000528	CcSEcCtD
Ipratropium bromide—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000134	0.000526	CcSEcCtD
Ipratropium bromide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000134	0.000525	CcSEcCtD
Ipratropium bromide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000133	0.000523	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000133	0.000521	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000131	0.000514	CcSEcCtD
Ipratropium bromide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000131	0.000514	CcSEcCtD
Ipratropium bromide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000129	0.000508	CcSEcCtD
Ipratropium bromide—Asthenia—Metformin—type 2 diabetes mellitus	0.000129	0.000508	CcSEcCtD
Ipratropium bromide—Hypotension—Ramipril—type 2 diabetes mellitus	0.000128	0.000503	CcSEcCtD
Ipratropium bromide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000128	0.000502	CcSEcCtD
Ipratropium bromide—Pruritus—Metformin—type 2 diabetes mellitus	0.000127	0.000501	CcSEcCtD
Ipratropium bromide—Urticaria—Losartan—type 2 diabetes mellitus	0.000127	0.000499	CcSEcCtD
Ipratropium bromide—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000126	0.000497	CcSEcCtD
Ipratropium bromide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000126	0.000494	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000125	0.000492	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000125	0.000491	CcSEcCtD
Ipratropium bromide—Rash—Valsartan—type 2 diabetes mellitus	0.000125	0.00049	CcSEcCtD
Ipratropium bromide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000125	0.000489	CcSEcCtD
Ipratropium bromide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000124	0.000488	CcSEcCtD
Ipratropium bromide—Insomnia—Ramipril—type 2 diabetes mellitus	0.000124	0.000487	CcSEcCtD
Ipratropium bromide—Headache—Valsartan—type 2 diabetes mellitus	0.000124	0.000487	CcSEcCtD
Ipratropium bromide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000123	0.000484	CcSEcCtD
Ipratropium bromide—Rash—Orlistat—type 2 diabetes mellitus	0.000123	0.000484	CcSEcCtD
Ipratropium bromide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000123	0.000484	CcSEcCtD
Ipratropium bromide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000123	0.000484	CcSEcCtD
Ipratropium bromide—Headache—Orlistat—type 2 diabetes mellitus	0.000122	0.000481	CcSEcCtD
Ipratropium bromide—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000122	0.00048	CcSEcCtD
Ipratropium bromide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000122	0.000479	CcSEcCtD
Ipratropium bromide—Somnolence—Ramipril—type 2 diabetes mellitus	0.000122	0.000479	CcSEcCtD
Ipratropium bromide—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000121	0.000474	CcSEcCtD
Ipratropium bromide—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00012	0.000472	CcSEcCtD
Ipratropium bromide—Dizziness—Metformin—type 2 diabetes mellitus	0.000119	0.000468	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000118	0.000465	CcSEcCtD
Ipratropium bromide—Fatigue—Ramipril—type 2 diabetes mellitus	0.000118	0.000464	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000118	0.000463	CcSEcCtD
Ipratropium bromide—Nausea—Valsartan—type 2 diabetes mellitus	0.000117	0.000461	CcSEcCtD
Ipratropium bromide—Constipation—Ramipril—type 2 diabetes mellitus	0.000117	0.000461	CcSEcCtD
Ipratropium bromide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000116	0.000457	CcSEcCtD
Ipratropium bromide—Nausea—Orlistat—type 2 diabetes mellitus	0.000116	0.000456	CcSEcCtD
Ipratropium bromide—Asthenia—Losartan—type 2 diabetes mellitus	0.000115	0.000451	CcSEcCtD
Ipratropium bromide—Vomiting—Metformin—type 2 diabetes mellitus	0.000114	0.00045	CcSEcCtD
Ipratropium bromide—Rash—Metformin—type 2 diabetes mellitus	0.000114	0.000446	CcSEcCtD
Ipratropium bromide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000113	0.000446	CcSEcCtD
Ipratropium bromide—Pruritus—Losartan—type 2 diabetes mellitus	0.000113	0.000445	CcSEcCtD
Ipratropium bromide—Headache—Metformin—type 2 diabetes mellitus	0.000113	0.000443	CcSEcCtD
Ipratropium bromide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000112	0.000442	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000112	0.000441	CcSEcCtD
Ipratropium bromide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000109	0.00043	CcSEcCtD
Ipratropium bromide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000109	0.000428	CcSEcCtD
Ipratropium bromide—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000108	0.000426	CcSEcCtD
Ipratropium bromide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000108	0.000425	CcSEcCtD
Ipratropium bromide—Rash—Irbesartan—type 2 diabetes mellitus	0.000107	0.000421	CcSEcCtD
Ipratropium bromide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000107	0.000421	CcSEcCtD
Ipratropium bromide—Nausea—Metformin—type 2 diabetes mellitus	0.000107	0.00042	CcSEcCtD
Ipratropium bromide—Headache—Irbesartan—type 2 diabetes mellitus	0.000106	0.000418	CcSEcCtD
Ipratropium bromide—Dizziness—Losartan—type 2 diabetes mellitus	0.000106	0.000415	CcSEcCtD
Ipratropium bromide—Vomiting—Losartan—type 2 diabetes mellitus	0.000102	0.000399	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000101	0.000397	CcSEcCtD
Ipratropium bromide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000101	0.000397	CcSEcCtD
Ipratropium bromide—Rash—Losartan—type 2 diabetes mellitus	0.000101	0.000396	CcSEcCtD
Ipratropium bromide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000101	0.000396	CcSEcCtD
Ipratropium bromide—Headache—Losartan—type 2 diabetes mellitus	0.0001	0.000394	CcSEcCtD
Ipratropium bromide—Asthenia—Ramipril—type 2 diabetes mellitus	9.84e-05	0.000387	CcSEcCtD
Ipratropium bromide—Pruritus—Ramipril—type 2 diabetes mellitus	9.7e-05	0.000381	CcSEcCtD
Ipratropium bromide—Nausea—Losartan—type 2 diabetes mellitus	9.5e-05	0.000373	CcSEcCtD
Ipratropium bromide—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.38e-05	0.000369	CcSEcCtD
Ipratropium bromide—Dizziness—Ramipril—type 2 diabetes mellitus	9.07e-05	0.000356	CcSEcCtD
Ipratropium bromide—Vomiting—Ramipril—type 2 diabetes mellitus	8.72e-05	0.000343	CcSEcCtD
Ipratropium bromide—Rash—Ramipril—type 2 diabetes mellitus	8.64e-05	0.00034	CcSEcCtD
Ipratropium bromide—Dermatitis—Ramipril—type 2 diabetes mellitus	8.64e-05	0.000339	CcSEcCtD
Ipratropium bromide—Headache—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000338	CcSEcCtD
Ipratropium bromide—Nausea—Ramipril—type 2 diabetes mellitus	8.14e-05	0.00032	CcSEcCtD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.84e-06	9.78e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.83e-06	9.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.8e-06	9.74e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.79e-06	9.73e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	9.78e-06	9.72e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.75e-06	9.7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.74e-06	9.69e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	9.74e-06	9.69e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.7e-06	9.65e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.68e-06	9.63e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.68e-06	9.63e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.68e-06	9.62e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.66e-06	9.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.65e-06	9.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	9.59e-06	9.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.56e-06	9.51e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	9.54e-06	9.49e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	9.54e-06	9.49e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	9.54e-06	9.49e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	9.54e-06	9.49e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	9.51e-06	9.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.5e-06	9.45e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.47e-06	9.42e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	9.42e-06	9.36e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.39e-06	9.34e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.38e-06	9.33e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	9.37e-06	9.32e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.36e-06	9.31e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	9.29e-06	9.24e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	9.28e-06	9.23e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.27e-06	9.22e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—INS—type 2 diabetes mellitus	9.27e-06	9.21e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	9.14e-06	9.08e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.12e-06	9.06e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	9.11e-06	9.06e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	9.1e-06	9.05e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	9.09e-06	9.03e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	9.08e-06	9.03e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.07e-06	9.02e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	9e-06	8.95e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	8.99e-06	8.94e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.96e-06	8.91e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.96e-06	8.9e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.92e-06	8.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.92e-06	8.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.89e-06	8.84e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.8e-06	8.75e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	8.76e-06	8.71e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	8.76e-06	8.71e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	8.76e-06	8.71e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	8.76e-06	8.71e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	8.73e-06	8.68e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	8.63e-06	8.58e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	8.63e-06	8.58e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.55e-06	8.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.52e-06	8.47e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.51e-06	8.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.44e-06	8.39e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	8.42e-06	8.37e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.4e-06	8.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.39e-06	8.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.37e-06	8.32e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.29e-06	8.24e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	8.28e-06	8.23e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	8.28e-06	8.23e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	8.2e-06	8.16e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	8.18e-06	8.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.13e-06	8.08e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.13e-06	8.08e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	8.1e-06	8.05e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	7.93e-06	7.88e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.82e-06	7.78e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.81e-06	7.76e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.8e-06	7.76e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.8e-06	7.75e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	7.79e-06	7.75e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.78e-06	7.73e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—INS—type 2 diabetes mellitus	7.78e-06	7.73e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	7.77e-06	7.72e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.72e-06	7.68e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.7e-06	7.66e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	7.69e-06	7.65e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.66e-06	7.62e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RELA—type 2 diabetes mellitus	7.65e-06	7.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.64e-06	7.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	7.64e-06	7.59e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	7.64e-06	7.59e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	7.61e-06	7.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	7.61e-06	7.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.56e-06	7.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.55e-06	7.51e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	7.54e-06	7.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	7.54e-06	7.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.52e-06	7.48e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.45e-06	7.41e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.29e-06	7.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.2e-06	7.16e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.18e-06	7.14e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.14e-06	7.1e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.14e-06	7.1e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	7.13e-06	7.09e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.13e-06	7.09e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	7.13e-06	7.09e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.11e-06	7.07e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	7.1e-06	7.06e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	7.01e-06	6.97e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7e-06	6.96e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.96e-06	6.92e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.96e-06	6.92e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.96e-06	6.92e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.96e-06	6.92e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.91e-06	6.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.9e-06	6.86e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.85e-06	6.81e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	6.82e-06	6.78e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	6.82e-06	6.78e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.81e-06	6.77e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	6.8e-06	6.76e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.79e-06	6.75e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.79e-06	6.75e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.72e-06	6.69e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.71e-06	6.67e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	6.62e-06	6.58e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	6.52e-06	6.49e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.52e-06	6.48e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	6.5e-06	6.47e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	6.49e-06	6.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.45e-06	6.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	6.44e-06	6.4e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.42e-06	6.38e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.4e-06	6.36e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	6.36e-06	6.32e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.34e-06	6.3e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	6.34e-06	6.3e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.32e-06	6.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.31e-06	6.27e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.31e-06	6.27e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.29e-06	6.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.29e-06	6.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.28e-06	6.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.26e-06	6.22e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.24e-06	6.2e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.24e-06	6.2e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.24e-06	6.2e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	6.24e-06	6.2e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.23e-06	6.19e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.22e-06	6.19e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.2e-06	6.16e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	6.17e-06	6.14e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.13e-06	6.09e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.09e-06	6.06e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.07e-06	6.04e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SRC—type 2 diabetes mellitus	6.01e-06	5.98e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.99e-06	5.96e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.97e-06	5.94e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.94e-06	5.91e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.92e-06	5.88e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.85e-06	5.82e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	5.85e-06	5.81e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	5.74e-06	5.7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.72e-06	5.69e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.72e-06	5.69e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.71e-06	5.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.7e-06	5.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.7e-06	5.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.65e-06	5.62e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.65e-06	5.62e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.64e-06	5.61e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.64e-06	5.61e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	5.56e-06	5.52e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	5.46e-06	5.43e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.44e-06	5.41e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.41e-06	5.38e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.41e-06	5.38e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.39e-06	5.35e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	5.38e-06	5.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.37e-06	5.34e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	5.37e-06	5.34e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.32e-06	5.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.27e-06	5.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.9e-06	4.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.89e-06	4.86e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.86e-06	4.83e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.84e-06	4.81e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.84e-06	4.81e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.83e-06	4.8e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.81e-06	4.78e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.79e-06	4.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.76e-06	4.74e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.74e-06	4.71e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.66e-06	4.64e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.66e-06	4.64e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.65e-06	4.62e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.64e-06	4.62e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.59e-06	4.56e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.58e-06	4.55e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.58e-06	4.55e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.54e-06	4.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.53e-06	4.51e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.53e-06	4.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.48e-06	4.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.45e-06	4.43e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.45e-06	4.42e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.44e-06	4.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.39e-06	4.37e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.33e-06	4.3e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	4.26e-06	4.24e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.25e-06	4.22e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.23e-06	4.21e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.22e-06	4.19e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.18e-06	4.15e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.16e-06	4.13e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.14e-06	4.12e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.12e-06	4.1e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.11e-06	4.09e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.08e-06	4.05e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.08e-06	4.05e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.07e-06	4.05e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	4.05e-06	4.03e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.03e-06	4.01e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.98e-06	3.96e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.82e-06	3.8e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.78e-06	3.76e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.77e-06	3.75e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.75e-06	3.73e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.74e-06	3.71e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.73e-06	3.71e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.73e-06	3.71e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.71e-06	3.69e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.7e-06	3.68e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.66e-06	3.64e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.63e-06	3.61e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.57e-06	3.55e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.56e-06	3.54e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.52e-06	3.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	3.14e-06	3.12e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.1e-06	3.08e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.04e-06	3.02e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.85e-06	2.83e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.84e-06	2.83e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.81e-06	2.8e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.79e-06	2.77e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.67e-06	2.65e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.67e-06	2.65e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.63e-06	2.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.62e-06	2.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.6e-06	2.58e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.44e-06	2.42e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.87e-06	1.86e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.23e-06	1.22e-05	CbGpPWpGaD
